These products are often compared by consumers to prescription GLP-1 medications, but they are not FDA-approved drugs, are not clinically equivalent to GLP-1 receptor agonists, and ingredient-level research differs significantly from finished-product trials
This recommendation is based on the lack of human safety data and concerns about potential risks to a developing fetus
Generell gilt, dass es bei gleichzeitiger Einnahme anderer Medikamente zu Wechselwirkungen kommen kann
Comorbidities : Other metabolic conditions, such as the presence of type 2 diabetes, osteoarthritis, obstructive sleep apnea, and heart disease, also influence the effect of medication
Highlights of Prescribing Information: Xenical (orlistat) Capsules, for oral use
Efficacy was measured by monitoring changes in glycated hemoglobin (HbA1c) and body weight at week 12